BlackRock, Inc. 13D and 13G filings for Cullinan Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 4,338,725 7.500% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 4,338,725 7.500% | 1,589,995 (+57.84%) | Filing |
| 2024-06-07 1:30 pm Purchase | 2024-05-31 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 2,748,730 4.800% | 286,456 (+11.63%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 2,462,274 5.800% | 425,623 (+20.90%) | Filing |
| 2023-09-07 09:38 am Sale | 2023-08-31 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 2,036,651 4.800% | -469,564 (-18.74%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 2,506,215 5.500% | 2,506,215 (New Position) | Filing |